» Articles » PMID: 22689191

Maternal Autoantibodies in Autism

Overview
Journal Arch Neurol
Specialty Neurology
Date 2012 Jun 13
PMID 22689191
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

As epidemiologic studies continue to note a striking increase in rates of autism spectrum disorder (ASD) diagnosis around the world, the lack of identified causative agents in most cases remains a major hindrance to the development of treatment and prevention strategies. Published observations of immune system abnormalities in ASD have increased recently, with several groups identifying fetal protein reactive IgG antibodies in plasma from mothers of children with autism. Furthermore, other gestational immune parameters, including maternal infection and dysregulated cytokine signaling, have been found to be associated with ASD in some cases. While detailed pathogenic mechanisms remain to be determined, the hypothesis that some cases of ASD may be influenced, or even caused, by maternal fetal brain-reactive antibodies or other in utero immune-related exposures is an active area of investigation. This article reviews the current literature in this area and proposes several directions for future research.

Citing Articles

Interplay of polygenic liability with birth-related, somatic, and psychosocial factors in anorexia nervosa risk: a nationwide study.

Papini N, Presseller E, Bulik C, Holde K, Larsen J, Thornton L Psychol Med. 2024; 54(9):2073-2086.

PMID: 38347808 PMC: 11323254. DOI: 10.1017/S0033291724000175.


Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review.

Yenkoyan K, Mkhitaryan M, Bjorklund G Curr Med Chem. 2024; 31(17):2345-2360.

PMID: 38204225 DOI: 10.2174/0109298673252471231121045529.


Maternal autoimmune disease and risk of offspring autism spectrum disorder - a nationwide population-based cohort study.

Chen C, Lin C, Lin M Front Psychiatry. 2023; 14:1254453.

PMID: 38025447 PMC: 10654781. DOI: 10.3389/fpsyt.2023.1254453.


The association between maternal infection and intellectual disability in children: A systematic review and meta-analysis.

Rezaeinejad M, Riahi S, Behzad Moghadam K, Tadi M, Geraili Z, Parsa H PLoS One. 2023; 18(10):e0292226.

PMID: 37796792 PMC: 10553326. DOI: 10.1371/journal.pone.0292226.


Conceptualizing Epigenetics and the Environmental Landscape of Autism Spectrum Disorders.

Torres G, Mourad M, Iqbal S, Moses-Fynn E, Pandita A, Siddhartha S Genes (Basel). 2023; 14(9).

PMID: 37761876 PMC: 10531442. DOI: 10.3390/genes14091734.


References
1.
CHESS S . Autism in children with congenital rubella. J Autism Child Schizophr. 1971; 1(1):33-47. DOI: 10.1007/BF01537741. View

2.
Ozonoff S, Young G, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L . Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics. 2011; 128(3):e488-95. PMC: 3164092. DOI: 10.1542/peds.2010-2825. View

3.
Morris C, Zimmerman A, Singer H . Childhood serum anti-fetal brain antibodies do not predict autism. Pediatr Neurol. 2009; 41(4):288-90. DOI: 10.1016/j.pediatrneurol.2009.04.014. View

4.
Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H . Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res. 2005; 96(8):823-30. DOI: 10.1161/01.RES.0000163016.52653.2e. View

5.
Singer H, Morris C, Gause C, Gillin P, Crawford S, Zimmerman A . Antibodies against fetal brain in sera of mothers with autistic children. J Neuroimmunol. 2007; 194(1-2):165-72. DOI: 10.1016/j.jneuroim.2007.11.004. View